XML 16 R5.htm IDEA: XBRL DOCUMENT v3.22.2
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Common Stock
Additional Paid-in Capital
Additional Paid-in Capital
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Other Comprehensive Loss
Accumulated Deficit
Accumulated Deficit
Cumulative Effect, Period of Adoption, Adjustment
Beginning balance (in shares) at Mar. 31, 2021     109,135          
Beginning balance at Mar. 31, 2021 $ 160,504   $ 109 $ 755,643   $ (4,193) $ (591,055)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock under stock plans, less withholding (in shares)     1,562          
Issuance of common stock under stock plans, less withholding 3,440   $ 2 3,438        
Stock-based compensation expense 36,508     36,508        
Unrealized investment loss (33)         (33)    
Foreign currency translation adjustment 283         283    
Net loss (43,906)           (43,906)  
Ending balance (in shares) at Jun. 30, 2021     110,697          
Ending balance at Jun. 30, 2021 156,796   $ 111 795,589   (3,943) (634,961)  
Beginning balance (in shares) at Mar. 31, 2022     117,863          
Beginning balance at Mar. 31, 2022 182,366 $ (46,160) $ 118 956,599 $ (92,832) (7,913) (766,438) $ 46,672
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock under stock plans, less withholding (in shares)     1,796          
Issuance of common stock under stock plans, less withholding 65   $ 2 63        
Stock-based compensation expense 31,807     31,807        
Unrealized investment loss (94)         (94)    
Foreign currency translation adjustment (8,419)     (35)   (8,384)    
Net loss (26,043)           (26,043)  
Ending balance (in shares) at Jun. 30, 2022     119,659          
Ending balance at Jun. 30, 2022 $ 133,522   $ 120 $ 895,602   $ (16,391) $ (745,809)